These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20399390)

  • 1. Marked improvement in Segawa syndrome after L-dopa and selegiline treatment.
    Yosunkaya E; Karaca E; Basaran S; Seven M; Yüksel A
    Pediatr Neurol; 2010 May; 42(5):348-50. PubMed ID: 20399390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopa-responsive dystonia (Segawa syndrome).
    Kamal N; Bhat DP; Carrick E
    Indian Pediatr; 2006 Jul; 43(7):635-8. PubMed ID: 16891685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine hydroxylase deficiency in Taiwanese infants.
    Chi CS; Lee HF; Tsai CR
    Pediatr Neurol; 2012 Feb; 46(2):77-82. PubMed ID: 22264700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dopa-responsive dystonia (Segawa syndrome) with secondary skeleton deformity].
    Budrewicz SP; Góral M; Koszewicz M; Tarantowicz P; Podemski R
    Wiad Lek; 2006; 59(9-10):713-5. PubMed ID: 17338136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of late-onset Segawa syndrome (autosomal dominant dopa-responsive dystonia) with a novel mutation of the GTP-cyclohydrase I (GCH1) gene.
    Furuya H; Murai H; Takasugi K; Ohyagi Y; Urano F; Kishi T; Ichinose H; Kira J
    Clin Neurol Neurosurg; 2006 Dec; 108(8):784-6. PubMed ID: 16289769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segawa disease with a novel heterozygous mutation in exon 5 of the GCH-1 gene (E183K).
    Ikeda T; Kanmura K; Kodama Y; Sawada K; Nunoi H; Hasegawa K
    Brain Dev; 2009 Feb; 31(2):173-5. PubMed ID: 18621497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dopa-responsive dystonia--a hereditary dystonia easy to treat].
    Farbu E; Bindoff LA
    Tidsskr Nor Laegeforen; 2002 Feb; 122(4):379-81. PubMed ID: 11915666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tyrosine hydroxylase deficiency: a case of autosomal recessive dopa-responsive dystonia].
    Tan D; Zhang Y; Ye J; Han L; Qiu W; Gu X; Zhang H
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):616-9. PubMed ID: 25224241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies].
    Furukawa Y
    Rinsho Shinkeigaku; 2006 Jan; 46(1):19-34. PubMed ID: 16541791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine hydroxylase deficiency with severe clinical course: clinical and biochemical investigations and optimization of therapy.
    Dionisi-Vici C; Hoffmann GF; Leuzzi V; Hoffken H; Bräutigam C; Rizzo C; Steebergen-Spanjers GC; Smeitink JA; Wevers RA
    J Pediatr; 2000 Apr; 136(4):560-2. PubMed ID: 10753262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopa-responsive dystonia presenting as delayed and awkward gait.
    Cheyette BN; Cheyette SN; Cusmano-Ozog K; Enns GM
    Pediatr Neurol; 2008 Apr; 38(4):273-5. PubMed ID: 18358407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of secondary dystonia responding to levodopa.
    Bernard G; Vanasse M; Chouinard S
    J Child Neurol; 2010 Jun; 25(6):780-1. PubMed ID: 19808991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in the tyrosine hydroxylase gene in the first Czech patient with tyrosine hydroxylase deficiency.
    Szentiványi K; Hansíková H; Krijt J; Vinšová K; Tesařová M; Rozsypalová E; Klement P; Zeman J; Honzík T
    Prague Med Rep; 2012; 113(2):136-46. PubMed ID: 22691284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Widening horizons" in the clinical application of selegiline].
    Kovács A
    Acta Pharm Hung; 1992 Sep; 62(5):259-64. PubMed ID: 1488911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of dopa-responsive dystonia.
    Ichinose H; Suzuki T; Inagaki H; Ohye T; Nagatsu T
    Biol Chem; 1999 Dec; 380(12):1355-64. PubMed ID: 10661862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOPA-sensitive progressive dystonia of childhood with fluctuations of symptoms--Segawa's syndrome and possible variants. Results of a collaborative study of the European Federation of Child Neurology Societies (EFCNS).
    Deonna T
    Neuropediatrics; 1986 May; 17(2):81-5. PubMed ID: 3724992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease.
    Brannan T; Yahr MD
    Ann Neurol; 1995 Jan; 37(1):95-8. PubMed ID: 7818264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broadening the phenotype of childhood-onset dopa-responsive dystonia.
    Chaila EC; McCabe DJ; Delanty N; Costello DJ; Murphy RP
    Arch Neurol; 2006 Aug; 63(8):1185-8. PubMed ID: 16908750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A long-term clinical effect of selegiline hydrochloride on Parkinson's disease].
    Mizuno Y; Kondo T; Takubo H; Yokochi F
    No To Shinkei; 1996 May; 48(5):467-72. PubMed ID: 8672306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with levodopa and/or selegiline does not affect behavioral recovery induced by fetal ventral mesencephalic grafts in unilaterally 6-hydroxydopamine-lesioned rats.
    Adams CE; Hoffman AF; Hudson JL; Hoffer BJ; Boyson SJ
    Exp Neurol; 1994 Dec; 130(2):261-8. PubMed ID: 7867755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.